Confronto

Bremelanotide vs. Sekretin

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

189691-06-3

nessun dato

Peso molecolare

1025.18 g/mol

3055.5 g/mol

Emivita

2.7 h

nessun dato

Sequenza

Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH

nessun dato

Meccanismo d'azione

Bremelanotide

Bremelanotide is a cyclic peptide that binds non-selectively to melanocortin receptors (MC1R through MC5R) — with highest affinity at MC4R in the central nervous system. The precise role of MC4R activation in sexual behaviour is not fully understood; animal data show effects on hypothalamic circuits. Peripheral effects (blood pressure, hyperpigmentation) are attributed to MC1R/MC2R.

Sekretin

Secretin binds the Gs-coupled secretin receptor (SCTR) on pancreatic duct cells, opens CFTR chloride channels and triggers secretion of bicarbonate-rich pancreatic fluid and bile flow.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studio sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Bremelanotide	Sekretin
Australia	Limitato	—
Germania	Non approvato	Su prescrizione
Stati Uniti	Su prescrizione	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Bremelanotide and Sekretin?: Bremelanotide is classified as "Ricerca (altro)", while Sekretin is classified as "Ricerca (altro)". Bremelanotide: Synthetic cyclic heptapeptide acting as a non-selective melanocortin-receptor agonist. FDA-approved in 2019 as Vyleesi for hypoactive sexual desire disorder (HSDD) in pre-menopausal women. Sekretin: Secretin is a 27-amino-acid hormone that regulates pancreatic bicarbonate secretion. As ChiRhoStim it is FDA-approved as a diagnostic agent (pancreatic function test, gastrinoma test, secretin-enhanced MRCP). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Bremelanotide or Sekretin?: The highest available evidence level is "RCT sull'uomo" for Bremelanotide and "Studio sull'uomo" for Sekretin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Bremelanotide and Sekretin in Germany and the United States?: Germania: Bremelanotide — Non approvato, Sekretin — Su prescrizione. Stati Uniti: Bremelanotide — Su prescrizione, Sekretin — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Bremelanotide

Sekretin

Australia

Limitato

—

Germania

Non approvato

Su prescrizione

Stati Uniti

Su prescrizione

Frequently asked questions

What is the difference between Bremelanotide and Sekretin?

Bremelanotide is classified as "Ricerca (altro)", while Sekretin is classified as "Ricerca (altro)". Bremelanotide: Synthetic cyclic heptapeptide acting as a non-selective melanocortin-receptor agonist. FDA-approved in 2019 as Vyleesi for hypoactive sexual desire disorder (HSDD) in pre-menopausal women. Sekretin: Secretin is a 27-amino-acid hormone that regulates pancreatic bicarbonate secretion. As ChiRhoStim it is FDA-approved as a diagnostic agent (pancreatic function test, gastrinoma test, secretin-enhanced MRCP). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Bremelanotide or Sekretin?

The highest available evidence level is "RCT sull'uomo" for Bremelanotide and "Studio sull'uomo" for Sekretin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Bremelanotide and Sekretin in Germany and the United States?

Germania: Bremelanotide — Non approvato, Sekretin — Su prescrizione. Stati Uniti: Bremelanotide — Su prescrizione, Sekretin — Su prescrizione. These are factual summaries with source and review date on the individual pages.